Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2013; 19(29): 4679-4688
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4679
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4679
Table 5 Adverse events related to treatment
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Hematological | ||||
| Leukopenia | 26% | 38% | 8% | 0% |
| Neutropenia | 10% | 26% | 30% | 12% |
| Anemia | 26% | 48% | 26% | 0% |
| Thrombocytopenia | 30% | 18% | 44% | 0% |
| Non-hematological | ||||
| Total bilirubin | 30% | 28% | 10% | 0% |
| AST | 20% | 36% | 38% | 6% |
| ALT | 48% | 12% | 16% | 2% |
- Citation: Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, Oh JS, Chun HJ, Lee HG, Choi JY, Yoon SK. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2013; 19(29): 4679-4688
- URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4679.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i29.4679